You are here

  • Home
  • Archive
  • Volume 31, Issue 11
  • ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)

Article metrics

Article menu

Download PDFPDF

Clinical trial
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)

 

Online download statistics by month:

Online download statistics by month: September 2021 to November 2022

AbstractFullPdf
Sep 2021456455166
Oct 2021383373119
Nov 2021728726135
Dec 2021748740523
Jan 202213171313949
Feb 2022135813461146
Mar 202233733079
Apr 2022116311661066
May 2022174917451518
Jun 2022133813441093
Jul 202227527363
Aug 202220619575
Sep 202221821274
Oct 202221620771
Nov 202210810645
Total10600105317122